FROM BENCH TO BEDSIDE
PAI Life Sciences provides developmental and translational research bringing products from the laboratory to the bedside.
PAI Life Sciences is a premiere supplier of adjuvants to the world's leading research organizations.
Serving the Underserved
Our mission is to address neglected diseases throughout the world with the idea of “Serving the Underserved.”
PAI Life Sciences has developed novel protein biotherapeutics and has a pipeline of products ranging from infectious disease vaccines and adjuvants to therapeutics for cancer.
We take on the challenges that are forgotten or overlooked by others
PAI is developing vaccines and treatments for neglected diseases
Schistosomiasis
Lymphatic Filariasis
Tuberculosis
Onchocerciasis
PAI News
PAI Life Sciences Doses First Healthy Volunteer in Schistosomaisis Vaccine Clinical Trial
•
May 31, 2022
PRESS RELEASE Deadly topical disease threatens hundreds of millions worldwide. SEATTLE– May 31, 2022 –PAI Life Sciences, a biotechnology company specializing in translational research for neglected tropical diseases, today announced
